TheraCann and K2 Principal Resolve Legal Dispute, Clearing Path for Growth

Toronto, Wednesday, 9 July 2025.
TheraCann International finalizes a confidential settlement with K2 Principal Fund, enabling collaboration with Sprout AI in cannabis technology and boosting investor confidence.